Puma Biotechnology Inc - Common Stock — Cash Flow (NASDAQ:PBYI) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities 773 K20.65 M-15.83 M27.01 M38.92 M41.8 M 41.15 M Cash from investing activities 23.4 M-10.88 M7.1 M-19.13 M-20.44 M-36.19 M -16.02 M Cash from financing activities 68 K-31.93 M12.22 M0-33.85 M-45.2 M -45.34 M Free cash flow 773 K20.65 M-15.83 M27.01 M38.92 M41.73 M 41.16 M

News

Is Puma Biotechnology (PBYI) a Great Value Stock Right Now?

PBYI Q2 Earnings & Sales Beat Estimates, 2026 Guidance Raised

Puma Biotech (PBYI) Q2 Earnings and Revenues Top Estimates

Earnings Preview: Puma Biotech (PBYI) Q2 Earnings Expected to Decline

Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why

PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised

Puma Biotechnology, Inc. (PBYI) Q1 2026 Earnings Call Transcript

Puma Biotechnology, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-05-08

Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Beats Revenue Estimates

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?

Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?